TrialBritish journal of clinical pharmacology2025

Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria.

Valérie Cosson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.